At Fevertree? |
Sales / volumes |
Growth of what? |
Nielsen June data shows strong growth on continent and US . Even U.K. doing well |
Am I the only one that things this one is behaving weirdly.? It’s all over the place with no news. And v little reaction here too. I suppose it’s just one to tuck away sand forget, if not needing the cash. |
Ah yes see that now buoy. Sorry
Thanks
Market weakness currently responsible but I am still wary of the high PE here |
They made a trading statement only a month ago saying everything was in line. |
Profit warning coming? |
FEVR - better to under promise than over promise. Doubt it's lost on them that their forecasts contradict their "margin improvements" for FY23.DOCS - Wasn't brilliant, fairly flat earnings now unless the BB is their ace up the sleeve to deliver a beat. Did post up. |
Good interchange.
Appreciated.
apad |
AndyThanks for posting, tend to agree as even best case their EBITDA margin will be lower than last year at 10.8%.They have mentioned previously that due to energy costs for glass production that this alone is likely to incur £20m in additional input costs for FY23. So perhaps any decent reduction here (+20%) could push margins above last year and a beat rather than a profit warn could be on the cards. Who knows but for me their freight and glass costs will at some point normalise to return to bottom line growth - can't see them changing product pricing anytime soon. |
evenue
UK 116.2 118.3 (2)%
US 95.6 77.9 23%
Europe (Fever-Tree brand
revenue) 89.2 78.6 13%
Europe total revenue* 101.0 88.2 14%
ROW 31.5 26.7 18%
Total 344.3 311.1 11%
Gross profit 118.8 130.9 (9)%
Gross margin 34.5% 42.1% (760)bps
Adjusted EBITDA[1] 39.7 63.0 (37)%
Adjusted EBITDA margin 11.6% 20.2% (870)bps
Diluted EPS (pence per share) 21.32 38.19 (44)%
Ordinary Dividend (pence
per share) 16.31 15.99 2%
Net cash 95.3 166.2 (43)%
------------------------------- ------ ------ ----
The above is from the last results.
What i dont get is that 390/405m is guidance for the current year.
However EBITDA is only 36/42 million.
So £50m plus growth but nothing falling to the bottom line.
So either pricing is wrong or they are giving margin away for growth ?
I think the period has been behind forecasts and a profit warning might be coming.
As a distributor there is a slow down in gin sales etc.
Diluted eps in the low 20`s means this is on a p/e of 65 times.
DYOR
Tiger |
So you bought at 850, surprised you didn't sell at 1750 |
Https://seekingalpha.com/news/3966479-fevertree-drinks-denies-retained-morgan-stanley-strategic-review |
Thanks, but Fevertree have refuted that it retained MS for a strategic review, but they hired them for corporate broking.This is being played IMO for day trading. |
Article saying Morgan Stanley have been appointed to conduct a strategic review |
Traders atm causing volatility IMO. |
What caused that sudden rise?! |
The last time it shot up like this,it lost the lot the next day.So not celebrating yet!(I'm up 66.66% on my initial purchase) |
Was just going to say that !! |
Deafening silence here ! No clinking of glasses at all. ? |
I am disc.
It fits what I see on Linkedin about treating every State as a new country, linking with spirit brands, etc.
apad |
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Hot Features
Premium
